V
Vicente Estrada
Researcher at Hospital Clínico San Carlos
Publications - 162
Citations - 5636
Vicente Estrada is an academic researcher from Hospital Clínico San Carlos. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 28, co-authored 147 publications receiving 4020 citations. Previous affiliations of Vicente Estrada include Complutense University of Madrid.
Papers
More filters
Journal ArticleDOI
Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).
Juan Berenguer,Rosa Polo,José López Aldeguer,Fernando Lozano,Koldo Aguirrebengoa,Jose R. Arribas,José Ramón Blanco,Vicente Boix,José L. Casado,Bonaventura Clotet,Manuel Crespo,Pere Domingo,Vicente Estrada,Federico García,José M. Gatell,Juan González-García,Félix Gutiérrez,José Antonio Iribarren,Hernando Knobel,Josep M. Llibre,Jaime Locutura,Juan Carlos López,José M. Miró,Santiago Moreno,Daniel Podzamczer,Joaquín Portilla,Federico Pulido,Esteban Ribera,Melchor Riera,Rafael Rubio,Jesús Santos,José Sanz-Moreno,Jesús Sanz,María Jesús Téllez,Montserrat Tuset,Antonio Rivero +35 more
TL;DR: In this update, antiretroviral therapy (ART) is recommended for all patients infected by type 1 human immunodeficiency virus and for patients who experience virological failure, in which case the rescue regimen should include three (or at least two) drugs that are fully active against HIV.
Journal Article
The COVID-19 curve, health system overload, and mortality
Iván J. Núñez-Gil,Vicente Estrada,Cristina Fernández-Pérez,Inmaculada Fernández-Rozas,Francisco Javier Martín-Sánchez,Carlos Macaya +5 more
Journal ArticleDOI
Role of Baseline Human Immunodeficiency Virus Genotype as a Predictor of Viral Response to Tenofovir in Heavily Pretreated Patients
Ana Barrios,Carmen de Mendoza,Luz Martín-Carbonero,Esteve Ribera,Pere Domingo,María José Galindo,Juan Gálvez,Vicente Estrada,David Dalmau,Victor Asensi,Vincent Soriano +10 more
TL;DR: In this paper, patients who failed antiretroviral therapy after exposure to compounds from all three drug families were monitored for 6 months after beginning a rescue intervention program including tenofovir (TDF).
Journal ArticleDOI
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial
Rocio Montejano,F. de la Calle-Prieto,María Velasco,Carlos Guijarro,J. Queiruga-Parada,M.C. Jiménez-González,P González-Ruano,Patricia Martínez,Ane Josune Goikoetxea,Marta Ibarrola,Mar Ciudad,Ángela Gutiérrez,Miguel Torralba,A. Díaz-Brasero,Pablo Ryan,Cristina Marcelo,Cristina Diez,Sofía Ibarra,Esperanza Merino,Vicente Estrada,Javier Godino-Ivan Marcos,Maria Teresa Novella,M. A. Rivera,Manuel Ruiz-Muñoz,M. de Miguel,Llanos Soler,Mikel Del Álamo,Santiago Moreno,Antonio J. Carcas,Alberto M. Borobia,Jose R. Arribas +30 more
TL;DR: The trial was stopped before reaching planned sample size due to the decrease in the number of cases and a mortality rate substantially lower than expected and the results do not suggest a beneficial effect of TDF/FTC; nevertheless, they are compatible with thebeneficial effect of baricitinib already established by other clinical trials.
Journal ArticleDOI
Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.
José Antonio Iribarren,Rafael Rubio,Koldo Aguirrebengoa,Jose R. Arribas,Josu Baraia-Etxaburu,Félix Gutiérrez,Juan Carlos López Bernaldo de Quirós,Juan Emilio Losa,José Ma Miró,Santiago Moreno,José Pérez Molina,Daniel Podzamczer,Federico Pulido,Melchor Riera,Antonio Rivero,José Sanz Moreno,Concha Amador,Antonio Antela,Piedad Arazo,Julio Arrizabalaga,Pablo Bachiller,Carlos Barros,Juan Berenguer,Joan A. Caylà,Pere Domingo,Vicente Estrada,Hernando Knobel,Jaime Locutura,José López Aldeguer,JM Llibre,Fernando Lozano,Josep Mallolas,Eduardo Malmierca,Celia Miralles,Pilar Miralles,Agustín Muñoz,Agustín Ocampo,Julián Olalla,Inés Rubio Pérez,Ma Jesús Pérez Elías,José Luis Pérez Arellano,Joaquín Portilla,Esteban Ribera,Francisco Gutiérrez Rodríguez,Miguel Santin,Jesús Sanz,M. J. Téllez,Miguel Torralba,Eulalia Valencia,Miguel A. Von Wichmann +49 more
TL;DR: Previous guidelines on the prevention and treatment of various OIs in HIV-infected patients, namely, infections by parasites, fungi, viruses, mycobacteria, and bacteria, as well as imported infections are updated.